Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q4 2018 · 10-K
Revenue$233.55M$233.55M+2.4% vs Q4 2017 Net Income$11.88M$11.88MN/M vs Q4 2017 EPS Diluted$0.22$0.22N/M vs Q4 2017 Gross Profit$104,386,000+27.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$57,627,000+66.7% Free Cash Flowderived$38,524,000+103.2% Margins · derivedGross margin44.7%+8.7 pt vs Q4 2017
Operating margin6.1%+31.3 pt vs Q4 2017
Net margin5.1%+27.5 pt vs Q4 2017
ended Mar 31, 2018 · filed May 23, 2018 · 53 d after period end